logo
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

AMA Classifies Obesity as a "Disease;" Obesity Drugs Now Could be Covered

  +Follow June 20, 2013 2:51PM
Share:
Tickers Mentioned:

BurgerOn Wednesday, the American Medical Association (AMA) officially declared obesity to be a disease. The AMA currently defines obesity as having a Body Mass Index (BMI) of over 30. At previous points, the AMA had referred to obesity as a “major health concern,” a “complex disorder,” and an “urgent chronic condition.” But moving obesity classification of “disease” will have several implications. Notably, if obesity is no longer considered merely a lifestyle choice in need of tweaking, insurance companies could be required to cover the cost of weight loss drugs. According to Vivus, approximately 30 percent of insurers cover its obesity drugs. Some providers such as Aetna (AET) and Blue Shield do include coverage for weight loss drugs, but this new definition could cause that number to rise significantly.

This is news that could affect pharamceutical companies such as Arena and Vivus significantly.

Arena Pharmaceuticals, Inc. (ARNA)

This San Diego-based biopharmaceutical company could be a major beneficiary of the ADA’s declaration. On June 27,2012 the FDA approved the obesity-reduction drug lorcaserin, which will be marketed by Arena under the name Belviq. Belviq stimulates serotonin so patients feel satiated, and thus more full after meals.

Arena announced last week that after a few delays, they’d finally be rolling out Belviq. Since obesity is now considered a disease, Belviq could be covered under most insurance plans that currently force patients to pay out of pocket for obesity-reduction drugs. Belviq was specifically approved for patients with a BMI over 30, or people with a BMI over 27 who suffer from at least one obesity-related condition like high blood pressure, type-2 diabetes, or high cholesterol, which fits neatly into the AMA’s new parameters for defining obesity.

Arena suffered a setback earlier this year when they withdrew the European Union application for Belviq. Their stock opened the day at $7.60 a share on moderate trading, and is down nearly two percent on the day. Their next earnings report is August 7.

Vivus, Inc. (VVUS)

Mountain, California based Vivus beat Arena to the punch in the obesity pharmaceutical battle, rolling out their own drug Qsymia last September. And Qysmia, a combination of phentermine and topiramate, has been shown to produce weight loss more effectively than Belviq. Qysmia is currently also approved by the FDA for patients with a BMI over 30, or over 27 with blood pressure, type-2 diabetes, or high cholesterol.

Qysmia though, has faced sluggish sales despite outperforming Belviq on weight loss effectiveness. Analysts have speculated this might be due to Qysmia’s side effects, which include drowsiness, increased heart rate, and increased chance of birth defects for pregnant women. Belviq has a relatively clean safety profile in comparison.
Vivus opened the day at $14.15 a share and is seeing above-average volume. This is well down from Vivus’ high posted on July 18, 2012 of $31.21 a share. Their next earnings report is August 5.

Results for ARNA
Dov Boulstridgeksw
17 Apr 14 08:14:07
$ARNA Arena Pharmaceuticals Repo http://t.co/84nj4G0iuc
Research Chief
17 Apr 14 08:00:32
Do you think you should hold $MDU $AMD $MMM $ARNA #financialnews http://t.co/g0972ToEKK
Franco Gall
17 Apr 14 07:46:25
$NWL Get research on $ALL $FHN $ARNA Click http://t.co/ha1hMl1D23
biogemfinder
17 Apr 14 07:43:33
$ARNA YMB someone posted that there R 1.2M available shares to short. Means the demand to borrow has declined as it has been since jan 2014.
Sharon Conklin
17 Apr 14 07:38:09
$ARNA #Obesity: Combating an epidemic w neuroscience, genetics&behavioral science http://t.co/MwngH7hdq7 … http://t.co/cf6hkkoABN
Trystan Carson
17 Apr 14 07:37:45
$VC Here are some Stocks to Watch $ORCL $PPS $ARNA #singedinvestor http://t.co/64yg8yCeXK
Esau Brennanl
17 Apr 14 07:33:53
Considering investing in $MDRX $AVGO $ATK $ARNA #NASDAQ http://t.co/BOJF7wjOJ2
Danj
17 Apr 14 07:31:34
RT @biogemfinder: $ARNA he who ignores the potential of #Belviq with Tv ads & listens to punk @jimcramer will do so at his own peril! DO yo…
Joey
17 Apr 14 07:29:53
$arna wish I have more dry powder... All in on ARNA
biogemfinder
17 Apr 14 07:29:35
$ARNA I am not sure about @jimcramer s track record but I am 100% sure that he is giving a dangerous advice re arena. Some will lose big!
biogemfinder
17 Apr 14 07:27:16
$ARNA he who ignores the potential of #Belviq with Tv ads & listens to punk @jimcramer will do so at his own peril! DO your own DD for once!
Jean Bryant
17 Apr 14 07:26:43
Keeping my Eye on $JCP $WDC $LYB $ARNA #Stock http://t.co/czKAwQlsTD
Warren Buffett
17 Apr 14 07:22:37
.@SharonAConklin If only $ARNA could get a nice squeeze...
Jerri Busto
17 Apr 14 07:10:49
Are you Bullish on these #stocks $TDW $TMHC $SNA $ARNA #NASDAQ http://t.co/UGgtbBTEDf
Joelle Cosby
17 Apr 14 07:10:09
Stocks to Watch this week $LSI $HE $NBL $ARNA View now http://t.co/vV2V96EPOj
Rob McGavern
17 Apr 14 07:00:23
$IP It could be breaktout time on $JPM $DCI $ARNA #financial http://t.co/LXZKxpJ07D
Brecken Khamba
17 Apr 14 06:49:34
#Stocks you might want to sell $C $TWX $DNR $ARNA Give it a try http://t.co/RlKmD1NPMk
Sky Hunter
17 Apr 14 06:43:20
$ARNA Arena Pharmaceutical http://t.co/dRu6yYlWFk
Chi Amaya
17 Apr 14 06:37:32
#Pennystock Research on $SYMC $BRKR $FLR $ARNA #NSE http://t.co/4HMlk9mkwn
Money Major
17 Apr 14 06:33:40
Todays Stocks you should Watch $APH $CAR $MMM $ARNA #money http://t.co/QLmeTEW6nO
Al Keeton
17 Apr 14 06:29:27
$ARNA Arena Pharmaceuticals Repo http://t.co/x2eAIL57Lv
Kamren Martinez
17 Apr 14 06:25:44
Get great research on stocks $BF $CMA $CI $ARNA #money http://t.co/kAJ1w0p35o
Sharice Keegan
17 Apr 14 06:22:08
Here are some Stocks to Watch $LMT $ISCA $WFM $ARNA #Stock http://t.co/j75xVt9Pnq
Mariano Keifer
17 Apr 14 06:19:59
$SSYS Free research on $MKC $MD $ARNA Click http://t.co/mbXeRFxu7A
Marin Calderon
17 Apr 14 06:03:18
$CTL Get great research on stocks $BG $TDC $ARNA Check out http://t.co/RApGcOapiq
MayoClinicDietReview
17 Apr 14 05:55:13
RT @WeightLossBio: RT @ewenker: Weightloss with Belviq: She's back!! #belviq $arna http://t.co/bnb1IOP7D5 http://t.co/tN43BX7vfR
Research Picker
17 Apr 14 05:39:51
$WM #Stock Market Reports on stocks like $DTV $MDLZ $ARNA #moneymanagement http://t.co/CYfeSYoT2f
Clint Clark
17 Apr 14 05:38:00
Best research on #stocks such s $AEE $GNW $SPLK $ARNA #financial http://t.co/4D7ZMOzM6w
Deon Carter
17 Apr 14 05:37:09
$NFG Whats going on with $TKR $SIAL $ARNA #personalfinance http://t.co/ymEewbjWvE
Brenden Black
17 Apr 14 05:35:19
#Pennystock Research on $WCRX $CAR $AMT $ARNA #money http://t.co/5l8ZtQslcG
Stock Star
17 Apr 14 05:33:21
Is it breakout time on $BOKF $FHN $TRN $ARNA View now http://t.co/y8Efvq4HOs
Crew Daily
17 Apr 14 05:31:57
$ARNA Arena Pharmaceutical http://t.co/G6hAXq2e4x
carl s
17 Apr 14 05:30:15
RT @SharonAConklin: Arena Pharmaceuticals $ARNA Appears Poised to Breakout. - http://t.co/wOCZXM4Bup #Belviq GOOGLE TRENDS UP, It's going …
Sharon Conklin
17 Apr 14 05:28:54
$ARNA Large decline in short interest http://t.co/6gsP6hE1gx
Research Picker
17 Apr 14 05:27:28
$ARNA Arena Pharmaceuticals Repo http://t.co/j2vuOqJJ68
Adams Law Group, LLC
17 Apr 14 05:22:42
Google Trends: Belviq vs. Qsymia $ARNA $VVUS #Belviq #Qsymia $OREX #Obesity #FDA https://t.co/mKvI9k2Vgx
Shas'el
17 Apr 14 05:00:53
RT @SharonAConklin: JACC $ARNA Effect of Lorcaserin on preexisting valvulopathy -no progression of existing valvulopathy. http://t.co/ZKN0e…
Money Smith
17 Apr 14 04:50:53
Are you looking to buy $HRS $UNT $DVA $ARNA View now http://t.co/VkEFkrR0qK
#WeightLoss
17 Apr 14 04:45:10
RT @ewenker: Weightloss with Belviq: She's back!! #belviq $arna http://t.co/bnb1IOP7D5 http://t.co/tN43BX7vfR
Sharon Conklin
17 Apr 14 04:42:57
Arena Pharmaceuticals $ARNA Appears Poised to Breakout. - http://t.co/wOCZXM4Bup #Belviq GOOGLE TRENDS UP, It's going higher today!
Pike Dean
17 Apr 14 04:41:13
$WEN Are you considering selling $ARG $LLY $ARNA Try this http://t.co/XmF3um0VgT
Research Picker
17 Apr 14 04:33:50
Top Performing #Stocks today $APD $DHI $HRS $ARNA #financial http://t.co/L7dL4WaxlG
Almeda Hendrixike
17 Apr 14 04:30:04
$TDG Get great research on stocks $DNR $VMW $ARNA #investing http://t.co/JgJKalT9WN
Laci Jack
17 Apr 14 04:27:39
Earnings news on $CRS $TTC $AMT $ARNA #Stock http://t.co/3KKmPGxaPc
Jerri Busto
17 Apr 14 04:26:49
Best research on #stocks such s $SC $PH $FTR $ARNA Try this http://t.co/F6lhsnadWI
Fergus Hillo
17 Apr 14 04:21:55
$CME Seeking the next hot #pennystock $BRCM $AIZ $ARNA I suggest http://t.co/LHn8Uir1XW
Laci Jack
17 Apr 14 04:20:20
$CYN Are you looking for winners like $QEP $BBY $ARNA View now http://t.co/DY3as9DFPF
Louie O'Malley
17 Apr 14 04:12:20
#Pennystock Research on $CTXS $DEI $PCLN $ARNA Must see http://t.co/fFObouZqPr
Azucena Dorriseeu
17 Apr 14 04:09:57
$WDAY Are you thinking of selling $ADBE $ISCA $ARNA #financial http://t.co/DSceaGo5GM
Bertie Beyer
17 Apr 14 04:08:59
$UTHR Are you Bullish on these #stocks $NEE $ITC $ARNA View now http://t.co/zfyd6fIPzJ
				
				
  +Follow June 20, 2013 2:51PM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.